Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Cerny

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patientsDamien Ulveling, Sigrid Le Clerc, Aurélie Cobat, et al.
Nature Communications|June 30, 2015
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Gut Microbes|May 16, 2022
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2Werner C Albrich, Tarini Shankar Ghosh, Sinead Ahearn-Ford, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Swiss Medical Weekly|September 28, 2023
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort studyChristine Ludz, Guido Stirnimann, David Semela, et al.
Gastroenterology|July 31, 2012
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionEtienne Patin, Zoltán Kutalik, Julien Guergnon, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Nature Communications|December 24, 2014
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patientsDamien Ulveling, Sigrid Le Clerc, Aurélie Cobat, et al.
Nature Communications|June 30, 2015
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genesEwa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, et al.
Gut Microbes|May 16, 2022
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2Werner C Albrich, Tarini Shankar Ghosh, Sinead Ahearn-Ford, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Swiss Medical Weekly|September 28, 2023
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort studyChristine Ludz, Guido Stirnimann, David Semela, et al.
Gastroenterology|July 31, 2012
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionEtienne Patin, Zoltán Kutalik, Julien Guergnon, et al.
Pageof 10